Aptevo Therapeutics Inc. (APVO)
Designs antibodies to boost the immune system's ability to fight cancer.
$4.21+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-91.3%
The outlook
Aptevo Therapeutics trades at $4.21, near its 52-week low with price well below both short and long-term moving averages. Analyst sentiment leans heavily bearish overall, though the average price target sits about 506% above current levels—a significant disconnect suggesting wide disagreement on fair value. The stock shows minimal analyst consensus, making it a speculative and volatile position for casual investors.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +506% vs current price
Analyst price target
~12-month · 2 analysts$25.50average target+505.7% vs now
Now $4.21
Low $21.00High $30.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.2M
52-wk high
$53.28
52-wk low
$3.68
50-day avg
$4.65
200-day avg
$10.92
Trailing P/E
0.0